Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 15, 2003
Galantamine hydrobromide: an agent for Alzheimer's diseaseVictoria Zarotsky, John J Sramek, Neal R CutlerDrugs|July 12, 2002
Generalised anxiety disorder: treatment optionsJohn J Sramek, Victoria Zarotsky, Neal R CutlerCurrent Topics in Behavioral Neurosciences|March 5, 2011
The impact of gender on antidepressantsJohn J Sramek, Neal R CutlerContemporary Clinical Trials Communications|October 27, 2025
Establishing a clinical trial site: A primer for aspiring principal investigatorsJohn J Sramek, Modesto S Carrillo, Neal R CutlerDialogues in Clinical Neuroscience|February 10, 2017
Sex differences in the psychopharmacological treatment of depressionJohn J Sramek, Michael F Murphy, Neal R CutlerReviews on Recent Clinical Trials|February 10, 2021
Phase 1 Clinical Trials of Small Molecules: Evolution and State of the ArtJohn J Sramek, Michael F Murphy, Sherilyn Adcock, et al.Expert Opinion on Pharmacotherapy|January 9, 2003
Diagnosis and treatment of endometriosisEdyta J Frackiewicz, Victoria ZarotskyFrontiers in Oncology|February 20, 2026
Advancements in intratumoral therapies for liver tumorsSteven S Raman, Neal R Cutler, John J Sramek, et al.Current Medical Research and Opinion|June 24, 2010
Predictors of adherence among Alzheimer's disease patients receiving oral therapyBijan Borah, Patricia Sacco, Victoria ZarotskyCNS Neuroscience & Therapeutics|February 6, 2016
Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal SubjectsJohn J Sramek, Larry W Hardy, Peter Bieck, et al.Pageof 4